PURE Bioscience Reports Fiscal First Quarter 2022 Financial Results
15.12.2021 - PURE Bioscience, Inc. (OTCQB: PURE) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2021. Summary of ...
Source: wallstreet-online.de